This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
メニュー

Hideaki Sato
Luxna Biotech における President and CEO
スピーカー

アジェンダセッション

  • Recent Progress of Kuxna's Antisense Oligonucleotide Therapeutics Platform and Application to Neurological Diseases

    , 2:45pm
    セッションを見る

このイベントで

前へ
次へ
Tomomi Sato
Associate Director
Takeda Pharmaceutical Company Limited

Hideaki を TIDES Asia: Oligonucleotide & Peptide Therapeutics で見る